Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001398344-25-019284
Filing Date
2025-10-17
Accepted
2025-10-17 17:10:52
Documents
2

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13D/A  
1 primary_doc.xml SCHEDULE 13D/A 12072
2 fp0095930-1_ex991.htm EX-99.1 8913
  Complete submission text file 0001398344-25-019284.txt   22676
Mailing Address 2000 POWELL STREET, SUITE 1150 EMERYVILLE CA 94608
Business Address 2000 POWELL STREET, SUITE 1150 EMERYVILLE CA 94608 (510) 899-8800
NovaBay Pharmaceuticals, Inc. (Subject) CIK: 0001389545 (see all company filings)

EIN.: 680454536 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13D/A | Act: 34 | File No.: 005-83670 | Film No.: 251401511
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 330 PRIMROSE ROAD, SUITE 400 BURLINGAME CA 94010
Business Address 330 PRIMROSE ROAD, SUITE 400 BURLINGAME CA 94010 650-239-9049
POPLAR POINT CAPITAL MANAGEMENT LLC (Filed by) CIK: 0001588273 (see all company filings)

EIN.: 460530967 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13D/A